Autoimmune pancreatitis is an inflammation in the pancreas. It may be caused by the immune system attacking the pancreas. Autoimmune pancreatitis also is called AIP. Two subtypes of AIP are now recognized, type 1 and type 2.
Type 1 AIP is called IgG4-related disease (IgG4-RD). This type often affects multiple organs, including the pancreas, bile ducts in the liver, salivary glands, kidneys and lymph nodes.
Type 2 AIP seems to affect only the pancreas, although about one-third of people with type 2 AIP have associated inflammatory bowel disease.
Type 1 AIP can be mistakenly diagnosed as pancreatic cancer. The two conditions have overlapping symptoms, but very different treatments, so it is very important to distinguish one from the other.
Autoimmune pancreatitis, also called AIP, is difficult to diagnose. Often, it doesn't cause any symptoms. Symptoms of type 1 AIP are like those of pancreatic cancer.
Pancreatic cancer symptoms can include:
The most common sign of type 1 AIP is painless jaundice. About 80% of people with type 1 AIP have painless jaundice. This is caused by blocked bile ducts. People with type 2 AIP can have repeat episodes of acute pancreatitis. Pain in the upper abdomen, a common symptom of pancreatic cancer, is often absent in autoimmune pancreatitis.
Differences between type 1 and type 2 AIP are:
Autoimmune pancreatitis often doesn't cause any symptoms. See a healthcare professional, however, if you have unexplained weight loss, belly pain, jaundice or other symptoms that bother you.
Experts don't know what causes autoimmune pancreatitis, but it is thought to be caused by the body's immune system attacking healthy body tissue. This is known as an autoimmune disease.
The two types of AIP happen with different frequency in different parts of the world. In the United States, about 80% of people with autoimmune pancreatitis, also called AIP, have type 1.
People with type 1 AIP often:
People with type 2 AIP:
Autoimmune pancreatitis can cause a variety of complications.
Treatments for autoimmune pancreatitis, such as long-term steroid use, can cause complications. However, even with these complications, people who are treated for autoimmune pancreatitis have a typical life expectancy.
There is no established association between AIP and pancreatic cancer.
Autoimmune pancreatitis is hard to diagnose, because its symptoms are a lot like those of pancreatic cancer. However, an accurate diagnosis is extremely important. Undiagnosed cancer may result in delaying or not receiving necessary treatment.
People with AIP tend to have a general enlargement of the pancreas, but they also may have a mass in the pancreas. To pinpoint the diagnosis and determine the type of AIP, blood and imaging tests are necessary.
No single test or characteristic feature identifies autoimmune pancreatitis. Recommended guidelines for diagnosis use a combination of imaging, blood tests and biopsy results.
Specific tests may include:
Blood tests. You may have a test to check for elevated levels of an immunoglobulin called IgG4. IgG4 is produced by your immune system. People with type 1 AIP often have high levels of IgG4 in their blood. People with type 2 AIP usually do not.
However, a positive test doesn't necessarily mean that you have the disease. A small number of people who don't have autoimmune pancreatitis, including some with pancreatic cancer, also have high levels of IgG4 in their blood.
Endoscopic core biopsy. In this test, a medical professional called a pathologist studies a sample of pancreatic tissue in the laboratory. AIP has a distinctive appearance that can be easily recognized under a microscope by an expert pathologist. A small tube called an endoscope is inserted through the mouth into the stomach, guided by ultrasound. A sample of tissue is then removed from the pancreas using a special needle.
The challenge is getting a sample of tissue large enough to study, rather than just a few cells. This procedure is not widely available, and results may not be conclusive.
Immunosuppressants and immunomodulators. The disease can relapse. For type 1 AIP, the disease relapses about 30% to 50% of the time. For type 2 AIP, it relapses less than 10% of the time. Cases of relapse require additional treatment, sometimes long term.
To help reduce the serious side effects associated with extended steroid use, medicines that suppress or modify the immune system may be added to the treatment. These are sometimes called steroid-sparing medicines. You may be able to stop taking steroids altogether depending on your response to steroid-sparing medicine.
Immunosuppressants and immunomodulators include mycophenolate (CellCept), mercaptopurine (Purinethol, Purixan), azathioprine (Imuran, Azasan) and rituximab (Rituxan). In general, they have been used in small sample groups and long-term benefits are still being studied.
Start by seeing your healthcare team if you have symptoms that worry you. If your care team suspects you may have autoimmune pancreatitis, you may be referred to a health professional who specializes in digestive issues, called a gastroenterologist, or a health professional who specializes in issues related to the pancreas, called a pancreatologist.
Your time with the health professional is limited. To make the most of the time, bring a list of questions you have to the appointment. Here are some possible questions about autoimmune pancreatitis:
In addition to the questions that you've prepared to ask your healthcare professional, don't hesitate to ask questions that come up during your appointment.
Your healthcare professional is likely to ask you several questions. Being ready to answer them may allow more time later to cover points you want to address. Your care professional may ask: